Relationship of neuroleptic drug effects at brain dopamine, serotonin, alpha-adrenergic, and histamine receptors to clinical potency
about
Inhibition of protein kinase C signaling protects prefrontal cortex dendritic spines and cognition from the effects of chronic stress.Pyridoxine improves drug-induced parkinsonism and psychosis in a schizophrenic patientAn animal model of emotional blunting in schizophrenia.Zebrafish behavioral profiling identifies multitarget antipsychotic-like compounds.Altered exploration and sensorimotor gating of the chakragati mouse model of schizophrenia.Antimanic potency of typical neuroleptic drugs and affinity for dopamine D2 and serotonin 5-HT2A receptors--a new analysis of data from the archives and implications for improved antimanic treatments.Contribution of human cytochrome p-450 isoforms to the metabolism of the simplest phenothiazine neuroleptic promazineThe role of dopamine in reward and pleasure behaviour--review of data from preclinical research.Clozapine--a new and different neurolepticDevelopment of a FLIPR assay for the simultaneous identification of MrgD agonists and antagonists from a single screen.H1-histamine receptor affinity predicts short-term weight gain for typical and atypical antipsychotic drugs.Differential uptake of DNA-poly(ethylenimine) polyplexes in cells cultured on collagen and fibronectin surfaces.Peripheral and central adrenoceptor modulation of the behavioural effects of clozapine in the paw test.General anesthesia and altered states of arousal: a systems neuroscience analysis.Neuroleptic binding to human brain receptors: relation to clinical effects.The relationship of pineal calcification and melatonin secretion to the pathophysiology of tardive dyskinesia and Tourette's syndrome.Ventilatory stimulation by dopamine-receptor antagonists in the mouse.Common and distinct neural effects of risperidone and olanzapine during procedural learning in schizophrenia: a randomised longitudinal fMRI study.Typical and atypical antipsychotic drugs increase extracellular histamine levels in the rat medial prefrontal cortex: contribution of histamine h(1) receptor blockadeCharacterization of extrastriatal D2 in vivo specific binding of [¹⁸F](N-methyl)benperidol using PET.Clozapine: selective labeling of sites resembling 5HT6 serotonin receptors may reflect psychoactive profile.Validation of the reference tissue model for estimation of dopaminergic D2-like receptor binding with [18F](N-methyl)benperidol in humansAntischizophrenic drugs of the diphenylbutylpiperidine type act as calcium channel antagonists.Acepromazine inhibits hERG potassium ion channels expressed in human embryonic kidney 293 cells.Substituted benzamides as ligands for visualization of dopamine receptor binding in the human brain by positron emission tomographyGenetic variation associated with euphorigenic effects of d-amphetamine is associated with diminished risk for schizophrenia and attention deficit hyperactivity disorder.Dopamine D1 receptors, regulation of gene expression in the brain, and neurodegeneration.Antipsychotic occupancy of dopamine receptors in schizophrenia.Electrophysiology of the central serotonin system: receptor subtypes and transducer mechanisms.How have developments in molecular imaging techniques furthered schizophrenia research?Hyperemesis gravidarum: pathogenesis and the use of antiemetic agents.Impact of synaptic neurotransmitter concentration time course on the kinetics and pharmacological modulation of inhibitory synaptic currents.Modulation of sleep and waking states by D-1 receptors.Calcium antagonist receptors. Clinical and physiological relevance.SEURAT-1 liver gold reference compounds: a mechanism-based review.Presynaptic Dopamine Synthesis Capacity in Schizophrenia and Striatal Blood Flow Change During Antipsychotic Treatment and Medication-Free Conditions.Activation of the JAK-STAT pathway is necessary for desensitization of 5-HT2A receptor-stimulated phospholipase C signalling by olanzapine, clozapine and MDL 100907.Traditional receptor theory and its application to neuroreceptor measurements in functional imaging.Phosphoinositide system-linked serotonin receptor subtypes and their pharmacological properties and clinical correlates.The human dopamine D2 receptor gene is located on chromosome 11 at q22-q23 and identifies a TaqI RFLP.
P2860
Q24656155-2FE676C0-5AC0-4C98-8984-495FC56870A2Q28332518-5E97FCB7-9843-47E1-937F-B9C35F0DEE4CQ28471824-88F114EA-6549-465B-86FB-E79C85064107Q30369007-DF05FA25-5C5C-4133-BD98-27C5FB97FA15Q30405594-0FCA5DEE-C763-467C-A4BE-B40C4A43FFA8Q31163228-0CC46843-B66D-451C-978B-799D9FC64B30Q33186856-22F69426-2E4A-48D8-A8E6-64D4760E2367Q33214750-4C1F7E0A-40FF-466F-81C2-3A83531F7D4EQ33558385-525CDF8B-08F8-433B-8B61-3650ACB70832Q33714731-8A969D4F-DC33-47EB-AF25-2691A7A6DBC2Q33964839-0DA7C988-70DA-4A86-AD6E-8BA988659D4CQ34020793-3A2819D6-F7A3-4DAD-AAE6-98461862926DQ34059589-D98627B7-C4CD-47E1-8B49-7CB270652E7DQ34179988-A01C089C-82FD-4A5A-BF00-83563EB301E9Q34683448-95161497-76FE-48F0-92A2-CE72B2BC0CD5Q35281449-BC6F4C38-13DF-43EF-A0FC-AA615D2164DFQ35886740-0D93D255-B2D1-4A0A-AFC5-817397F41D55Q35946867-DDBCB592-0188-473B-8CBE-161F953F5B8CQ35966817-3B97EEA8-AEB7-471B-A0ED-F911FEC7B2FCQ36075795-E73611B3-AE41-4229-B504-5A8DBBBF6436Q36437587-68E31A5B-D22D-43BB-9C37-1B1A5491FAEBQ36666227-4C8E2B2E-D68B-4C74-BDBC-DEDE80E74E2DQ37346562-FFDB1D52-89C2-4703-8C6A-FCED315088FBQ37559594-96DA271F-7976-4C54-BCB5-EA578E1A48A5Q37690625-4659DD44-6277-458F-A4E5-032738FE299DQ37725363-2828E51A-CF5A-41D0-9CE1-21308CBD6EF3Q37772934-2D1052B5-8D12-4C77-B56A-620601ADA4A4Q37818511-698987ED-08D5-4969-9022-77B6EA691126Q37828705-FA0B15AD-7C24-4F61-BE55-E445D7C9B046Q37829639-3E06B6CE-EFFF-40D5-ACC6-E33C1381919EQ37848438-FD321602-D2C7-4BF9-870D-64E28434FFFAQ37898524-F3F1FF40-1D89-4D22-B442-879C8BC55A7CQ37980104-85A09A9A-1487-477D-BD55-50AC55C56CDDQ38188963-6FDB92E5-2327-4033-AD56-C1503CA441CAQ38268013-A956D566-EE19-42B9-BD8C-6823F6DC8931Q38848472-956AE6ED-F6F9-4A24-8F0E-85CF3333E8BBQ39922746-3A58F4C9-78C2-42A5-8116-BA50A122A344Q40382126-28843068-DA06-4B3C-804A-98B62084B116Q40548169-96DB4DC6-1A44-461F-B268-49E226CF1448Q40575056-21B2FD2B-E0C6-4909-A23D-5089BB2CC25B
P2860
Relationship of neuroleptic drug effects at brain dopamine, serotonin, alpha-adrenergic, and histamine receptors to clinical potency
description
1980 nî lūn-bûn
@nan
1980 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1980 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1980年の論文
@ja
1980年論文
@yue
1980年論文
@zh-hant
1980年論文
@zh-hk
1980年論文
@zh-mo
1980年論文
@zh-tw
1980年论文
@wuu
name
Relationship of neuroleptic dr ...... receptors to clinical potency
@ast
Relationship of neuroleptic dr ...... receptors to clinical potency
@en
Relationship of neuroleptic dr ...... receptors to clinical potency
@nl
type
label
Relationship of neuroleptic dr ...... receptors to clinical potency
@ast
Relationship of neuroleptic dr ...... receptors to clinical potency
@en
Relationship of neuroleptic dr ...... receptors to clinical potency
@nl
prefLabel
Relationship of neuroleptic dr ...... receptors to clinical potency
@ast
Relationship of neuroleptic dr ...... receptors to clinical potency
@en
Relationship of neuroleptic dr ...... receptors to clinical potency
@nl
P921
P3181
P356
P1476
Relationship of neuroleptic dr ...... receptors to clinical potency
@en
P2093
S H Synder
S J Peroutka
P304
P3181
P356
10.1176/AJP.137.12.1518
P407
P577
1980-12-01T00:00:00Z